3-(4-bromo-pyridin-2-yl)-N-methyl-propionamide | 1401311-31-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯并吡啶类
• 英文名称: 3-(4-bromo-pyridin-2-yl)-N-methyl-propionamide
• 英文别名: 3-(4-bromopyridin-2-yl)-N-methylpropanamide
• CAS: 1401311-31-6
• 化学式: C₉H₁₁BrN₂O
• 分子量: 243.103
• InChiKey: FEHUHAQEGDYDKK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  42
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• [EN] 3-UREIDOISOQUINOLIN-8-YL DERIVATIVES<br/>[FR] DÉRIVÉS DE 3-URÉIDOISOQUINOLÉIN-8-YLE
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2012131588A1

  公开（公告）日：2012-10-04

  The invention relates to 3-ureidoisoquinolin-8-yl derivatives of formula I I wherein R is alkyl, haloalkyl or cyclopropyl; R 2 is H, halogen, pyridazin-4-yl, pyrimidin-5-yl or an optionally substituted pyridin-3-yl, pyridin-4-yl or phenyl group; R 3 is alkyl, alkynyl, aminoalkyl, carbamoylalkyl, methylcarbamoylalkyl, alkoxy, haloalkoxy, alkynyloxy, (4-hydroxybut-2-yn-1-yl)oxy, (4-aminobut-2-yn-1-yl)oxy, dimethylaminoalkoxy, carbamoylalkoxy, alkylamino, cycloalkyl, cycloalkylalkyl, cycloalkylalkoxy, hydroxyalkyl, hydroxyalkoxy, alkoxyalkyl, alkoxyalkoxy, carboxyalkyl, carboxyalkoxy, alkoxycarbonylalkoxy, aryl, heteroaryl, benzyl, benzyloxy, 2-cyanoethoxy, 2,3-dihydroxypropoxy, 3,4-dihydroxybutoxy, -CH 2 R a, -CH 2 CH 2 R b, -(CH 2 ) n -C(O)O-R d, -(CH 2 ) n -N(R c )C(O)O-R d, -O-(CH 2 ) n -N(R c )C(O)O-R d, -(CH 2 ) n -R e or -O-(CH 2 ) n -R e; R a is cyano, acetylamino or N,N-dimethylamino; R b is cyano or carbamoyl; R c is H or methyl; R d is alkyl; R e is pyrrolidin-1-yl, piperidin-1-yl, piperidin-3-yl, morpholin-1-yl, 2-oxopyrrolidin-1-yl, 5-oxopyrrolidin-2-yl, 2,5-dioxopyrrolidin-1-yl, 2-oxoimidazolidin-1-yl, 4-(tert-butoxycarbonyl)piperazin-1-yl, 4-(aminomethyl)cyclohexyl or heteroaryl; R 4 is H or methyl; and to the salts of such compounds. These compounds are useful for the prevention or the treatment of bacterial infections.

  该发明涉及式I的3-脲基异喹啉-8-基衍生物，其中R为烷基、卤代烷基或环丙基；R2为H、卤素、吡啶并[4,5-d]嘧啶-4-基、嘧啶-5-基或可选择取代的吡啶-3-基、吡啶-4-基或苯基；R3为烷基、炔基、氨基烷基、氨基甲酰烷基、甲基氨基甲酰烷基、烷氧基、卤代烷氧基、炔基氧基、(4-羟基丁-2-炔-1-基)氧基、(4-氨基丁-2-炔-1-基)氧基、二甲胺基烷氧基、甲酰胺烷氧基、烷基氨基、环烷基、环烷基烷基、环烷基烷氧基、羟基烷基、羟基烷氧基、烷氧基烷基、烷氧基烷氧基、羧基烷基、羧基烷氧基、烷氧羰基烷氧基、芳基、杂环芳基、苄基、苄氧基、2-氰基乙氧基、2,3-二羟基丙氧基、3,4-二羟基丁氧基、- Ra、- Rb、-(CH2)n-C(O)O-Rd、-( )n-N(Rc)C(O)O-Rd、-O-( )n-N(Rc)C(O)O-Rd、-( )n-Re或-O-( )n-Re；Ra为氰基、乙酰氨基或N,N-二甲基氨基；Rb为氰基或甲酰基；Rc为H或甲基；Rd为烷基；Re为吡咯烷-1-基、哌啶-1-基、哌啶-3-基、吗啉-1-基、2-氧代吡咯烷-1-基、5-氧代吡咯烷-2-基、2,5-二氧代吡咯烷-1-基、2-氧代咪唑烷-1-基、4-(叔丁氧羰基)哌嗪-1-基、4-(氨甲基)环己基或杂环芳基；R4为H或甲基；以及这些化合物的盐。这些化合物对于预防或治疗细菌感染是有用的。
• 3-UREIDOISOQUINOLIN-8-YL DERIVATIVES
  申请人：Gude Markus

  公开号：US20140038961A1

  公开（公告）日：2014-02-06

  The invention relates to 3-ureidoisoquinolin-8-yl derivatives of formula I wherein R 1 is alkyl, haloalkyl or cyclopropyl; R 2 is H, halogen, pyridazin-4-yl, pyrimidin-5-yl or an optionally substituted pyridin-3-yl, pyridin-4-yl or phenyl group; R 3 is alkyl, alkynyl, aminoalkyl, carbamoylalkyl, methylcarbamoylalkyl, alkoxy, haloalkoxy, alkynyloxy, (4-hydroxybut-2-yn-1-yl)oxy, (4-aminobut-2-yn-1-yl)oxy, dimethylaminoalkoxy, carbamoylalkoxy, alkylamino, cycloalkyl, cycloalkylalkyl, cycloalkylalkoxy, hydroxyalkyl, hydroxyalkoxy, alkoxyalkyl, alkoxyalkoxy, carboxyalkyl, carboxyalkoxy, alkoxycarbonylalkoxy, aryl, heteroaryl, benzyl, benzyloxy, 2-cyanoethoxy, 2,3-dihydroxypropoxy, 3,4-dihydroxybutoxy, —CH 2 R a , —CH 2 CH 2 R b , —(CH 2 ) n —C(O)O—R d , —(CH 2 ) n —N(R c )C(O)O—R d , —O—(CH 2 ) n —N(R c )C(O)O—R d , —(CH 2 ) n —R e or —O—(CH 2 ) n —R e ; R a is cyano, acetylamino or N,N-dimethylamino; R b is cyano or carbamoyl; R c is H or methyl; R d is alkyl; R e is pyrrolidin-1-yl, piperidin-1-yl, piperidin-3-yl, morpholin-1-yl, 2-oxopyrrolidin-1-yl, 5-oxopyrrolidin-2-yl, 2,5-dioxopyrrolidin-1-yl, 2-oxoimidazolidin-1-yl, 4-(tert-butoxycarbonyl)piperazin-1-yl, 4-(aminomethyl)cyclohexyl or heteroaryl; R 4 is H or methyl; and to the salts of such compounds. These compounds are useful for the prevention or the treatment of bacterial infections.

  本发明涉及式I的3-尿素异喹啉-8-基衍生物，其中R1是烷基、卤代烷基或环丙基；R2是H、卤素、吡啶并[4,5-d]嘧啶-4-基、嘧啶并[4,5-d]嘧啶-5-基或可选取代的吡啶-3-基、吡啶-4-基或苯基；R3是烷基、炔基、氨基烷基、氨基甲酰烷基、甲基氨基甲酰烷基、烷氧基、卤代烷氧基、炔基氧基、(4-羟基丁-2-炔-1-基)氧基、(4-氨基丁-2-炔-1-基)氧基、二甲基氨基烷氧基、甲酰氨基烷氧基、烷基氨基、环烷基、环烷基烷基、环烷基氧基、羟基烷基、羟基烷氧基、烷氧基烷基、烷氧基氧基、羧基烷基、羧基烷氧基、烷氧羰基烷氧基、芳基、杂环芳基、苄基、苄氧基、2-氰乙氧基、2,3-二羟基丙氧基、3,4-二羟基丁氧基、- Ra、- Rb、-(CH2)n-C(O)O-Rd、-( )n-N(Rc)C(O)O-Rd、-O-( )n-N(Rc)C(O)O-Rd、-( )n-Re或-O-( )n-Re；Ra是氰基、乙酰氨基或N,N-二甲基氨基；Rb是氰基或甲酰基；Rc是H或烷基；Rd是吡咯烷-1-基、哌啶-1-基、哌啶-3-基、吗啉-1-基、2-氧代吡咯烷-1-基、5-氧代吡咯烷-2-基、2,5-二氧代吡咯烷-1-基、2-氧代咪唑烷-1-基、4-(叔丁氧羰基)哌嗪-1-基、4-(氨甲基)环己基或杂环芳基；R4是H或烷基；以及这些化合物的盐。这些化合物可用于预防或治疗细菌感染。
• US8889676B2
  申请人：——

  公开号：US8889676B2

  公开（公告）日：2014-11-18